טוען...
Thyroid and Hepatic Function After High Dose (131)I-Metaiodobenzylguanidine ((131)I-MIBG) Therapy for Neuroblastoma
BACKGROUND: (131)I-Metaiodobenzylguanidine ((131)I-MIBG) provides targeted radiotherapy for children with neuroblastoma, a malignancy of the sympathetic nervous system. Dissociated radioactive iodide may concentrate in the thyroid, and MIBG is concentrated in the liver after MIBG therapy. The aim of...
שמור ב:
| Main Authors: | , , , , , , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3006009/ https://ncbi.nlm.nih.gov/pubmed/20830775 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.22767 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|